AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05152641 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BGE-117, 12mg
Description: BGE-117, 12mg Capsules
Study NCT06128668 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Yoga
Description: Yoga will be applied
Study NCT05253872 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: The MelaCare intervention
Description: The primary principles applied will be:~* Meta-cognitive strategies and normalization of emotions~* Self efficacy related to SSE and knowledge on when to seek a doctor for clinical examination~The intervention will include 4 components:~* An educational booklet~* Doctor consultation to ensure correct SSE skills and compliance to the protocol~* 3-5 sessions with a experienced and specially trained melanoma nurse~* Use of patients' answers from the Patient Reported Outcome 'Functional Assessment of Cancer Treatment - Melanoma' (FACT-M) at the nurse sessions to address current emotional and/or physical sequelae.
Study NCT05474274 — intervention group
Intervention type: OTHER
Intervention: Machine learning algorithms
Description: Machine learning techniques to rank order physiologic variables obtained via the wearable and handheld devices as well as remove low-importance and redundant variables to accurately determine postoperative pain intensity in outpatients
Study NCT04711915 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: 0.1 mg/kg Dimethyltryptamine (DMT)
Description: 0.1 mg/kg DMT
Study NCT04711915 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: 0.3 mg/kg Dimethyltryptamine (DMT)
Description: 0.3 mg/kg DMT
Study NCT06220357 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Indocyanine Green
Description: The patients were split into three different groups, the patient were given ICG with three different concentrations in a double-blind randomized manner postoperatively. The fluorescence emitted was quantitatively analyzed using the ImageJ software to ascertain the mean gray values, providing a robust measure of the ICGA concentration. The imaging was captured using a FLUORO 4000XL type NIR camera, positioned at a distance of 15-20 cm perpendicular to the flap.
Study NCT06220357 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Indocyanine Green
Description: The patients were split into three different groups, the patient were given ICG with three different concentrations in a double-blind randomized manner postoperatively. The fluorescence emitted was quantitatively analyzed using the ImageJ software to ascertain the mean gray values, providing a robust measure of the ICGA concentration. The imaging was captured using a FLUORO 4000XL type NIR camera, positioned at a distance of 15-20 cm perpendicular to the flap.
Study NCT06669624 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Attachment and Biobehavioral Catch-up (ABC)
Description: 10-session home visiting intervention designed to increase parental sensitivity and nurturance and decrease parental frightening behavior.
Study NCT06669624 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Attachment and Biobehavioral Catch-up (ABC)
Description: 10-session home visiting intervention designed to increase parental sensitivity and nurturance and decrease parental frightening behavior.
Study NCT06669624 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Waitlist with 4-month delay, then ABC
Description: A 4-month waitlist period, after which they will also receive the home-based ABC program (same as Intervention group).
Study NCT06678178 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Control (QR) Labels
Description: Participants will view a fast-food restaurant menu including main, side, dessert, and drink items. Each menu item will be displayed with an image of the item, name, price, and total calories. For main items only, Control (QR) labels will be displayed beneath each item. Participants will be instructed to select up to 4 menu items for a hypothetical meal order.
Study NCT06678178 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Warning High Climate Impact Labels
Description: Participants will view a fast-food restaurant menu including main, side, dessert, and drink items. Each menu item will be displayed with an image of the item, name, price, and total calories. For main items only, Warning High Climate Impact labels will be displayed beneath select items. Participants will be instructed to select up to 4 menu items for a hypothetical meal order.
Study NCT04169282 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: nPEP (non-invasive positive expiratory pressure) mask
Description: Positive end expiratory pressure (PEEP) mask
Study NCT05079854 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Intraocular Instillation Solution
Description: Intracameral Moxifloxacin 0.5%
Study NCT05079854 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Moxifloxacin Ophthalmic
Description: Topical Moxifloxacin 0.5%
Study NCT06328725 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: EN001
Description: Phase 1~* Cohort 1: EN001 5.0x10\^5 cells/kg administered intravenously (IV) 3 times at 6 week intervals.~* Cohort 2: EN001 2.5x10\^6 cells/kg administered intravenously (IV) 3 times at 6 week intervals.~Phase 2~* Experimental Group: The recommended phase 2 dose (RP2D) of EN001 is administered intravenously (IV) three times at six-week intervals.~* Control Group: EN001 placebo is administered intravenously (IV) three times at six-week intervals.
Study NCT06375018 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Technique
Description: In the control group, manual contact will be carried out without any therapeutic intention. This contact will be maintained for the same period of time as the experimental group.
Study NCT06375018 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Diaphragm Stretching
Description: The participant will be in supine position and the researcher will be at the headrest of the examination table, placing his hands on the lower costal margin. Superior direction traction is performed during inspiration, remaining during expiration. The procedure is repeated for a maximum period of 4 minutes.
Study NCT06275087 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Propofol
Description: The experimental group will not receive volatile anesthetic, instead, they will receive propofol infusion
Study NCT06275087 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Sevoflurane
Description: The control group will not receive TIVA, instead, they will receive sevoflurane via inhalation
Study NCT06678178 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Traffic Light Labels
Description: Participants will view a fast-food restaurant menu including main, side, dessert, and drink items. Each menu item will be displayed with an image of the item, name, price, and total calories. For main items only, Traffic Light labels will be displayed beneath each item. Participants will be instructed to select up to 4 menu items for a hypothetical meal order.
Study NCT06678178 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Climate Grade Labels
Description: Participants will view a fast-food restaurant menu including main, side, dessert, and drink items. Each menu item will be displayed with an image of the item, name, price, and total calories. For main items only, Climate Grade labels will be displayed beneath each item. Participants will be instructed to select up to 4 menu items for a hypothetical meal order.
Study NCT06678178 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Numeric Carbon Footprint Labels
Description: Participants will view a fast-food restaurant menu including main, side, dessert, and drink items. Each menu item will be displayed with an image of the item, name, price, and total calories. For main items only, Numeric Carbon Footprint labels will be displayed beneath each item. Participants will be instructed to select up to 4 menu items for a hypothetical meal order.
Study NCT04967417 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pemetrexed, Carboplatin, Pembrolizumab
Description: * Pemetrexed 500mg/m2~* Carboplatin AUC 5.0~* Pembrolizumab 200mg
Study NCT04967417 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Paclitaxel, Carboplatin, Pembrolizumab
Description: * Paclitaxel 200mg/m2~* Caboplatin AUC 6.0~* Pembrolizumab 200mg
Study NCT06700343 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ocrelizumab (US)
Description: IV infusion
Study NCT06700343 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ocrelizumab (EU)
Description: IV infusion
Study NCT04675983 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sintilimab
Description: Administered IV
Study NCT04675983 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ramucirumab
Description: Administered IV
Study NCT06700343 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ABP 692
Description: IV infusion
Study NCT04675983 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Cisplatin
Description: Administered IV
Study NCT04675983 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: 5-fluorouracil
Description: Administered IV
Study NCT04675983 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Oxaliplatin
Description: Administered IV
Study NCT04675983 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Capecitabine
Description: Administered orally
Study NCT04658875 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Spirulina maxima supplementation
Description: Supplementation with Spirulina maxima (4.5 g/d) in capsules during 12 weeks.
Study NCT04658875 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Wash-out
Description: 2 weeks washout period to each study subject to avoid any possible carryover effect.
Study NCT04658875 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Wash-out
Description: 2 weeks washout period to each study subject to avoid any possible carryover effect.
Study NCT04658875 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Placebo supplementation
Description: Supplementation with placebo (4.5 g/d) in capsules during 12 weeks.
Study NCT04658875 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Placebo supplementation
Description: Supplementation with placebo (4.5 g/d) in capsules during 12 weeks.
Study NCT04658875 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Isoenergetic diet
Description: All participants will have a personal isoenergetic diet according to their height, weight, body composition and daily physical activity during 26 weeks
Study NCT04658875 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Isoenergetic diet
Description: All participants will have a personal isoenergetic diet according to their height, weight, body composition and daily physical activity during 26 weeks
Study NCT04658875 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Systematic physical exercise program
Description: Participants in the systematic physical exercise program groups will exercise for five days a week. The physical activity program will consist of Monday to Friday chair exercises performed during 24 weeks. The approximate exercise duration will be 40 to 50 min. Each exercise session has an initial or warm-up phase (\~ 10 min), a main physical conditioning phase (\~ 25 min), and a cool-down or relaxation phase (\~ 10 min). The physical activities to select have a metabolic equivalent tasks (METs) considered as moderate, between 3.0 and 6.0 METs. Trained personnel will assist older adults to perform the activities, including articular flexibility using elastic bands, postural and proprioception exercises with materials such as rubber balls, wood sticks, and small sandbags. These activities will be selected according to the deterioration and joint stiffness that the participants could present.
Study NCT05527210 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Prebiotic
Description: Prebiotin® is a fine, white to slightly yellow powder, which is mixed into water and has a slightly sweet taste.
Study NCT05527210 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Prebiotic
Description: Placebo prebiotic mixed into water
Study NCT06529029 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Sigma-Stim
Description: Right Ultra-Brief Low Amplitude Seizure Therapy at 600mA or 700mA vs Right Unilateral Ultra-Brief Standard ECT at 800mA.
Study NCT06529029 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Sigma-Stim
Description: Right Ultra-Brief Low Amplitude Seizure Therapy at 600mA or 700mA vs Right Unilateral Ultra-Brief Standard ECT at 800mA.
Study NCT06528717 — intervention group
Intervention type: PROCEDURE
Intervention: Carotid graft interposition
Description: In patients with extensive atherosclerotic carotid disease, when endarterectomy isn't feasible, replacement of the carotid artery with a graft is needed. Graft interposition can be performed either by end-to-end proximal and distal anastomoses in the undiseased common and internal carotid artery with ligation of the external carotid artery, or by side-to-end proximal anastomosis on the origin of the internal carotid artery and end-to-end distal anastomosis on the internal carotid artery with flow preservation in the external carotid artery.
Study NCT06527313 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Movement Mobilization Concept, Exercise and Tape
Description: Mulligan Concept MWM Mulligan Taping Mulligan Self Home Workout
Study NCT06527313 — intervention group
Intervention type: BEHAVIORAL
Group type: SHAM_COMPARATOR
Intervention: Sham Movement Mobilization Concept, Exercise and Tape
Description: The technique will be applied to cases in the sham group with only hand contact, without any slippage or rotation in any direction. Then, rigid taping will be applied without any tension or direction, and home exercises will be given.
Study NCT06723717 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Daily infusion of dornase alfa
Description: Daily infusion of dornase alfa at a dose of 125 microg/kg as an intravenous bolus until day 14 after SAH
Study NCT06733610 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: universal allogeneic anti-CD19/BCMA CAR T-cells
Description: A single injection of UCAR T-cells, referred to as universal allogeneic anti-CD19/BCMA CAR T-cells.
Study NCT06732739 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: percussions with teach-back breathing exercise
Description: patient will receive Teach Back Breathing Exercises like pursed lip breathing, DE breathing and diaphragmatic breathing Teach-back breathing exercises refer to a method of instructing individuals in breathing techniques and then having them demonstrate or teach back the instructions to ensure comprehension and mastery. This educational approach is commonly used in healthcare settings, particularly when teaching patients how to perform various breathing exercises for therapeutic purposes. Patients were informed about the importance of regular chest percussion I will use the clapping technique which provided by cupped hand for 3 minutes in 5 positions of drainage (upper lobes-apical and posterior segment, apical and anterior segment, right upper lobe-posterior segment, left upper lobe-posterior segment, lower lobes- apical segment) with assisted suction three times/shift for four days, and then each patient will be observed.
Study NCT06732739 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: PERCUSSION
Description: similar to Group A, each patient underwent individual interviews. Patients were educated on the significance of regular chest percussion. The clapping technique, executed with cupped hands, was applied for 3 minutes in five drainage positions (upper lobes - apical and posterior segment, apical and anterior segment, right upper lobe - posterior segment, left upper lobe - posterior segment, lower lobes - apical segment). This procedure, including assisted suction three times per shift, was administered for four consecutive days.
Study NCT06732739 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: PERCUSSION
Description: similar to Group A, each patient underwent individual interviews. Patients were educated on the significance of regular chest percussion. The clapping technique, executed with cupped hands, was applied for 3 minutes in five drainage positions (upper lobes - apical and posterior segment, apical and anterior segment, right upper lobe - posterior segment, left upper lobe - posterior segment, lower lobes - apical segment). This procedure, including assisted suction three times per shift, was administered for four consecutive days.
Study NCT06733948 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Dental stent
Description: Dental stent is personalised device for tongue depressing and immobilisation during RT. The aims are to reduce unnecessary RT doses to adjacent non-target healthy tissue, including the tongue, adjacent oral mucosa, parotid glands/ submandibular glands, and temporomandibular joints. Dentists will take impression of the teeth on moulds, and measure the height to raise the bite, the stent is then fabricated as methyl methacrylate resin in the dental laboratory. The resin base extends to the tongue and a flat plate depresses the tongue. This device will be placed before each RT fraction.
Study NCT06733948 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: No dental stent
Description: No dental stent used during chemoradiation treatment
Study NCT06731972 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Exercises
Description: Classical massage, stretching, functional exercises, electrical modalities, thermal agents, home exercises, etc., plus home exercises.
Study NCT06731972 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercises
Description: Classical massage, stretching, functional exercises, electrical modalities, thermal agents, home exercises, etc., plus home exercises.
Study NCT06731972 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Mobile game
Description: mobile application games (such as Temple Run, Flappy Bird, Angry Birds, etc., or games the patient is already playing) as part of their home exercise program.
Study NCT06733168 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: electrical impedance tomography
Description: Before initiating recruitment maneuver, all patients were placed on mechanical ventilation set according to the ARDSnetwork strategy for 10 minutes, ensuring SpO2 of 88-95%, PaO2 of 55-80 mmHg, and a mean arterial pressure (MAP) ≥ 65 mmHg.~* PEEP was incrementally increased by 5 cmH2O every minute: from 10 to 15, to 20, and finally to 25 cmH2O, with a maximum pressure limit of 40 cmH2O.~* Following recruitment maneuver at the final PEEP level, the process of identifying the optimal PEEP was initiated.~* Then, PEEP will be set to 20 cmH2O and was gradually decreased by 2 cmH2O every 30 seconds until it reached 6 cmH2O or SpO2 dropped to ≤ 80%.~* Selection of optimal PEEP: The optimal PEEP was defined as the intersection point between the alveolar overdistension and collapse curves as measured by the EIT system.
Study NCT06733168 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Non-EIT
Description: Patients will have PEEP set using the low FiO2-PEEP table, based on the ARDSnet protocol
Study NCT06732934 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: exercise (Basic Body Awareness Therapy
Description: Body Awareness Therapy is a patient-centered physiotherapy approach that also includes mental health, focusing on movement awareness training. This therapy primarily consists of exercises aimed at improving postural disorders, balance, and muscle tension. It aims to help individuals experience and accept bodily responses while increasing coping strategies.~The therapy includes body scanning, integration of sound and movement, stretching exercises, and exercises focusing on body alignment and midline orientation.~Floor exercises: body scanning, stretching, strength accumulation, sound resonance.~Seated exercises: body alignment, trunk rotation, head and neck movements. Standing exercises: support surface perception, midline elevation and lowering, bilateral arm movements, rotation, one-legged balance, voice exercises, and group movements.
Study NCT06732934 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: exercise (aerobic exercise)
Description: The continuous exercise protocol specified by the American College of Sports Medicine (ACSM) will be applied under supervision on a treadmill. The exercise duration will follow ACSM recommendations, starting at 30 minutes in the first week and increasing to 45 minutes by the 12th week.~Exercise intensity will be assessed using the target heart rate method (220 - age). The intensity of aerobic exercise will be set at a moderate level (64-77% HRmax), according to ACSM guidelines.~During exercise, heart rate will be monitored through a heart rate monitoring device. A 5-minute warm-up and a 5-minute cool-down exercise will be performed before and after each session, with an intensity of 50-60% of the maximum heart rate.
Study NCT06733805 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Portrait + Therapeutics Letter
Description: In the context of audit and feedback interventions, Portrait is a document produced by the physician organization Therapeutics Initiative that provides personalized prescribing feedback for BC clinicians. Portraits are used as a practice resource tool for reflection on prescribing patterns. Each Portrait topic provides data of individual prescriber's prescribing practice, benchmarks or targets, a succinct review of the best-available evidence on the topic, and recommendations for future action.~The Therapeutics Letter is a standalone publication that details identified problematic therapeutic issues in a brief, simple and practical manner. Therapeutics letters include a systematic literature review on a clinical topic, and provide reference for the data presented in the Portraits.
Study NCT06755073 — intervention group
Intervention type: RADIATION
Intervention: Pulmonary artery Doppler ultrasound
Description: Doppler ultrasound of fetal pulmonary artery